Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
MFR drug test 1
first
| Question | Answer |
|---|---|
| naturally occurring agent that can "chemically cardiovert" | ADENOSINE |
| it has a half-life of 10 seconds and does not cause hypotension | ADENOSINE |
| Indications: narrow, complex supraventricular tachycardia refractory to vagal maneuvers | ADENOSINE |
| Contraindications: Hypersensitivity, 2nd- and 3rd-degree hear block, sinus node disease, asthma | ADENOSINE |
| Dosage/Route: 6 mg rapidly (over 1-3 sec) IV, then flush the line rapidly with saline. If ineffective, 12 mg in 1-2 min, may be repeated | ADENOSINE |
| Doxage/Route: Ped: 0.1 mg/kg to a max of 6 mg (rapidly) IV followed by a rapid saline flush, then 0.2 mg/kg in 1-2 min to max 2nd dose of 12 mg | ADENOSINE |
| this absorbs and binds to toxins from the GI tract | ACTIVATED CHARCOAL |
| it is indicated for acute ingested poisoning | ACTIVATED CHARCOAL |
| Contraindications: an airway that cannot be controlled; ingestion of cyanide, mineral acids, caustic alkalis, organic solvents, iron, ethanol, and methanol | ACTIVATED CHARCOAL |
| Precautions: administer only after emesis or in those cases where emesis is contraindicated | ACTIVATED CHARCOAL |
| Dosage/Rotue: 1 1/kg mixed with at least 6 to 8 oz of water, then PO or via an NG tube | ACTIVATED CHARCOAL |
| this is a clinically proven analgesic/antipyretic with little effect on platelet function | ACETAMINOPHEN |
| indicated for mild to moderate pain and fever when aspirin is otherwise not tolerated | ACETAMINOPHEN |
| Contraindications: hypersensitivity, children under 3 years | ACETAMINOPHEN |
| Precautions: patients with hepatic disease, children under 12 years with arthritic conditions, alcoholism, malnutrition, thrombocytopenia | ACETAMINOPHEN |
| Dosage/Route: 325 to 650 mg. PO every 4-6 hours. 650 mg PR every 4-6 hours | ACETAMINOPHEN |
| this is a synthetic sympathomimetic that causes bronchodilation with less cardiac effect than epinephrine and reduces mucus secretion, pulmonary capillary leaking, and edema in the lungs durring allergic reactions | ALBUTEROL |
| indications are bronchospasm and asthma in COPD | ALBUTEROL |
| Contraindications: hypersensitivity to the drug | ALBUTEROL |
| Precautions: the patient may experience tachycardia, anxiety, nausea, cough, wheezing, and/or dizziness | ALBUTEROL |
| Dosage/Route: two inhalations (90mcg) via metered dose inhaler (2 sprays) or 2.5 mg in 2.5-3 mL NS via nebulizer, repeat as needed. the duration of effect is 3-6 hours | ALBUTEROL |
| Dosage/Route: Ped: 0.15 mg/kg in 2.5-3 mL NS via nebulizer, repeat as needded | ALBUTEROL |
| this interferes with the development of angiotension, reducing peripheral vascular resistance, blood pressure, and cardiac after load | ACE INHIBITORS |
| it is indicated in AME or heart failure without hypotension; hypertension | ACE INHIBITORS |
| Contraindications: pregnancy, hypersensitivity to the drug, elevated serum potassium, hypotension (<100 SBP), or hypovolemia; IV form is contraindicated in STEMI | ACE INHIBITORS |
| Precautions: renal failure | ACE INHIBITORS |
| Dosage/Route:Enalapril-- 2.5 mg PO, 1.25 mg IV over 5 min (IV form contraindicated in STEMI); Captopril-- 6.25 mg PO; Lisinopril-- 5 mg PO; Ramipril-- 2.5 mg PO | ACE INHIBITORS |
| promotes thrombolysis by forming plasmin. plasmin, in turn, degrades fibrin and fibrogen and, ultimately, the clot | ALTEPLASE RECOMBINANT |
| it is indicated to thrombolyse in acute myocardial infarction, acute ischemic stroke, and pulmonary embolism | ALTEPLASE RECOMBINANT |
| Contraindications: active internal bleeding, suspected aortic dissection, traumatic CPR, recent hemorrhagic stroke (6mo), intracranial or intraspinal surgery or trauma (2mo), pregnancy, uncontrolled hypertension, hypersensitivity to thrombolytics | ALTEPLASE RECOMBINANT |
| Precautions: recent major surgery, cerebral vascular disease, recent GI or GU bleeding, recent trauma, hypertension, patient > 75 years, current oral anticoagulants, hemorrhagic ophthalmic conditions | ALTEPLASE RECOMBINANT |
| Dosage/Route: MI: 15 mg IV, then .75 mg/kg (up to 50 mg) over 30min, then .5 mg/kg (up to 35 mg) over 60 min up to 100 mg | ALTEPLASE RECOMBINANT |
| Dosage/Route: Stroke: .09 mg/kg over 1 min. then .91 mg/kg (up to 90 mg) over next 60 min | ALTEPLASE RECOMBINANT |
| this is a methylxanthing that prolongs bronchodilation and decreased mucus production and has mild cardiac and CNS stimulating effects | AMINOPHYLLINE |
| its indications are bronchospasm in asthma and COPD refractory to sympathomimetics and other bronchodilators and in CHF | AMINOPHYLLINE |
| Contraindications: hypersensitivity to methylxanthines or uncontrolled cardiac dysrhythmias | AMINOPHYLLINE |
| Precautions: cardiovascular disease, hypertension or taking theophylline, hepatic impairment, diabetes, hyperthyroidism, young children, glaucoma, peptic ulcers, acute influenza or influenza immunization, the elderly | AMINOPHYLLINE |
| Dosage/Route: 250-500 mg IV over 20-30 min | AMINOPHYLLINE |
| Dosage/Route: Ped: 6 mg/kg over 20-30 min. max 12 mg/kg/day | AMINOPHYLLINE |
| this is an antidysrhythmic that prolongs the duration of the action potential and refractory period and relaxes smooth muscles, reducing peripheral vascular resistance and increasing coronary blood flow | AMIODERONE |
| indications in life-threatening recurrent ventricular and supraventricular dysrhythmias that have not responded to other antidysrhythmic agents | AMIODERONE |
| Contraindications: hypersensitivity, cardiogenic shock, severe sinus bradycardia, advanced heart block | AMIODERONE |
| Precautions: hepatic impairment, pregnancy, nursing mothers, children | AMIODERONE |
| Dosage/Route: V-Fib: 300mg IV push, then repeat dose of 150 mg IV push if needed. Ped: 5 mg/kg IV/IO, repeat up to total dose of 15mg/kg | AMIODERONE |
| Dosage/Route: V-Tach: 150-300 mg IV over 10min, then 1 mg/min over next 6 hours. Ped: 5 mg/kg IV/IO over 20-60min, repeat to total dose of 15 mg/kg | AMIODERONE |
| this inhibits agents that cause the production of inflammation, pain, and fever. | ASPRIN |
| relieves mild to moderate pain by acting on the peripheral nervous system, lowers body temp in fever, and powerfully inhibits platelet aggregation | ASPRIN |
| indicated in chest pain suggestive of an MI | ASPRIN |
| Contraindications: hypersensitivity to salicylates, active ulcer disease, asthma | ASPRIN |
| Precautions: allergies to other NSAIDs, bleeding disorders, children or teenagers with varicella or influenza-like symptoms | ASPRIN |
| Dosage/Route: 160-325 mg PO (chewable, non-enteric-coated) | ASPRIN |
| this is a selective beta blocker that reduces the rate and force of cardiac contraction and lowers cardiac output and blood pressure | ATENOLOL |
| indicated in non-Q-wave MI and unstable angina | ATENOLOL |
| Contraindications: sinus bradycardia, 2nd- or 3rd-degree heart block, CHF, cardiogenic failure or shock | ATENOLOL |
| Precautions: asthma, COPD, CHF controlled by digitalis and diuretics | ATENOLOL |
| Dosage/Route: 5 mg slow IV every 5 min. to 15 mg. Ped: .8 to 1.5 mg/kg/day PO (max 2 mg/kg/day) | ATENOLOL |
| this is related to furosemide, though it has a fasster rate of onset, a greater diuretic potency (40 times), shorter duration, and produces only mild hypotension | BUMETANIDE |
| indications to promote diuresis in CHF and pulmonary edema | BUMETANIDE |
| Contraindications: hypersensitivity to bumetanide and other sulfonamides | BUMETANIDE |
| Precautions: pregnancy (use only for life-threatening conditions) | BUMETANIDE |
| Dosage/Route; .5-1 mg I/IV over 1-2 min, repeat in 2-3 hours as needed | BUMETANIDE |
| this inhibits platelet aggregation and prolongs clotting time | CLOPIDOGREL |
| indicated in ST segment depression MI (non-STEMI) and dynamic T wave inversion and for MI and stroke patients who cannot tolerate asprin | CLOPIDOGREL |
| Contraindications: hypersensitivity to the drug, pathologic bleeding or bleeding risk | CLOPIDOGREL |
| Precautions: liver disease, pregnancy | CLOPIDOGREL |
| Dosage/Route; 300-600 mg PO | CLOPIDOGREL |
| this is a centrally acting synthetic narcotic analgesic about 5 times more potent than morphine. A schedule IV narcotic | BUTORPHANOL |
| indicated in moderate to severe pain | BUTORPHANOL |
| Contraindications: hypersensitivity, head injury, undiagnosed abdominal pain | BUTORPHANOL |
| Precautions: may cause withdrawl in narcotis-dependent patients | BUTORPHANOL |
| Dosage/Route: 1 mg IV or 3-4 mg IM over 3-4 hours | BUTORPHANOL |
| this is a long-acting synthetic adrenocorticoid with intense anti-inflammatory activity. it prevents the accumulation of inflammation generating cells at the sites of infection or injury | DEXAMETHASONE |
| it is indicated in anaphylaxis, asthma, COPD, spinal cord edema | DEXAMETHASONE |
| Contraindications: no absolute contraindications in the emergency setting. relative contraindications: systemic fungal infections, acute infections, TB, varicella, vaccine or live virus vaccinations | DEXAMETHASONE |
| Precautions: herpes simplex, keratitis, myasthenia gravis, hepatic or renal impairment, diabetes, CHF, seizures, psychic disorders, hypothyroidism, GI ulceration | DEXAMETHASONE |
| Dosage/Route: 4-24 mg IV/IM. Ped: .5-1 mg/kg | DEXAMETHASONE |
| this increases myocardial contractile force and increases ventricular automaticity | CALCIUM CHLORIDE |
| indicated in hyperkalemia, hypocalcemia, hypercalcemia, possible digitalis toxicity | CALCIUM CHLORIDE |
| Precautions: it may precipitate toxicity in patients taking digoxin. ensure the IV line is in a large vein and flushed before using and after calcium | CALCIUM CHLORIDE |
| Dosage/Route: 500-1000 mg IV (5-10 mL of 10% solution) as needed. Ped: 20 mg/kg IV/IO, as needed | CALCIUM CHLORIDE |
| this blocks the parasympathetic nervous system, specifically the vagal effects on heart rate | ATROPINE |
| this does not increase contractility but may increase myocardial oxygen demand | ATROPINE |
| it decreases airway secretions | ATROPINE |
| indications are hemodynamically significant bradycardia and organophosphate poisoning | ATROPINE |
| Contraindications: none in the emergency setting | ATROPINE |
| Precautions: AMI, glaucoma, hypothermic bradycardia | ATROPINE |
| Dosage/Route: Symptomatic Bradycardia: .5 mg IV repeat 3-5 min to 3mg. Ped: .02 mg/kg IV, .04-.06 mg/kg ET, may repeat IV dose once up to 1 mg for child or 3 mg for adolescent | ATROPINE |
| Dosage/Route: Organophosphae poisoning: 2-5 mg IV/IM/IO/10-15 min. Ped: .05 mg/kg IV/IM/IO/10-15 min | ATROPINE |
Created by:
rubtuge
Popular Paramedic/EMT sets